Gopi Kumar Mittapalli

This inventor holds 24 USPTO granted patents and 10 published patent applications and 4 EPO patents, primarily in Carboxamide Compounds. Top assignees: Samumed, LLC, Biosplice Therapeutics, Inc., Tenarx, Inc.. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gopi Kumar Mittapalli. Retrieved from https://idiyas.com/inventor/gopi-kumar-mittapalli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 10)

% Patents Active = 100.0

EPO Patents = 4 (Patent Applications = 12)

Average Co-Inventor Count = 6.8

ph-index = 4

Forward Citations = 98(Granted Patents)

Company Filing History:

Biosplice Therapeutics, Inc.

Years Active: 2017-2026

Loading Chart...

Areas of Expertise:

Isoquinolin

Indazole

Carboxamides

5-Heteroaryl

Pyrrolo

Triazines

Therapeutic Uses

Macrocycles

Diazanaphthalen

Substituted Compounds

Heteroaryl

Preparation

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12729205 - 4-alkoxypyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof (2026-09-08),

2. 12281097 - Isoquinolin-3-yl carboxamides and preparation and use thereof (2025-04-21),

3. 12134625 - Pyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof (2024-11-05),

4. 11713320 - 5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof (2023-08-01),

5. 11673881 - Isoquinolin-3-yl carboxamides and preparation and use thereof (2023-06-13),

6. 11548872 - Isoquinolin-3-yl carboxamides and preparation and use thereof (2023-01-10),

7. 11174244 - Isoquinolin-3-yl carboxamides and preparation and use thereof (2021-11-16),

8. 10947217 - Isoquinolin-3-YL carboxamides and preparation and use thereof (2021-03-16),

9. 10934297 - 5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof (2021-03-02),

10. 10759799 - Indazole containing macrocycles and therapeutic uses thereof (2020-09-01),

11. 10744128 - 6-(5-membered heteroaryl)isoquinolin-3-yl-(5-membered heteroaryl) carboxamides and preparation and use thereof (2020-08-18),

12. 10703748 - Diazanaphthalen-3-yl carboxamides and preparation and use thereof (2020-07-07),

13. 10669240 - 5-substituted indazole-3-carboxamides and preparation and use thereof (2020-06-02),

14. 10653688 - 6-(6-membered heteroaryl and aryl)isoquinolin-3-yl carboxamides and preparation and use thereof (2020-05-19),

15. 10604514 - 6-(5-membered heteroaryl)isoquinolin-3-yl carboxamides and preparation and use thereof (2020-03-31),

Title: Gopi Kumar Mittapalli: Innovator in Pharmaceutical Patents

Introduction

Gopi Kumar Mittapalli, based in San Diego, CA, is an accomplished inventor with a remarkable portfolio of 23 patents. His work focuses on developing innovative pharmaceuticals targeting a variety of diseases, showcasing his commitment to advancing medical science.

Latest Patents

Among his latest patents are significant contributions such as "Isoquinolin-3-yl carboxamides and preparation and use thereof." This patent addresses the use of isoquinoline compounds in treating disorders linked to the activation of Wnt pathway signaling, which includes conditions like cancer, abnormal cellular proliferation, and osteoarthritis. Another notable patent is centered around "Pyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof," which focuses on combating diseases characterized by the overexpression of DYRK1A, including Alzheimer’s disease and Down syndrome. These patents demonstrate Gopi Kumar Mittapalli's dedication to tackling complex medical challenges through innovative solutions.

Career Highlights

Throughout his career, Gopi Kumar Mittapalli has played a pivotal role in several notable companies. He has contributed his expertise at Samumed, LLC, and Biosplice Therapeutics, Inc., where he has been instrumental in the development of groundbreaking pharmaceutical technologies. His experience in these organizations has strengthened his capability to drive innovation in the pharmaceutical landscape.

Collaborations

Gopi Kumar Mittapalli has worked alongside skilled professionals in the industry, including Chi Ching Mak and Sunil Kumar Kc. These collaborations have not only enhanced his perspective on product development but have also led to significant advancements in their respective fields of study.

Conclusion

Gopi Kumar Mittapalli stands out as a distinguished inventor with a robust patent portfolio and a strong commitment to innovation in the pharmaceutical sector. His contributions are poised to make a lasting impact on the treatment of various diseases, reflecting his dedication to enhancing human health through scientific advancements.

Profile summary based on public USPTO records.